drugset / Trial / NCT06734273

Randomized Control Trial of Sleeve Gastrectomy With Tirzepatide in Maximizing Weight Loss

NCT06734273

Phase 0 Recruiting 42 enrolled Nicholas Skertich
RandomizedParallel-groupOpen-labelTreatment

Summary

This study examines whether adding tirzepatide-a medication that helps with weight loss-after sleeve gastrectomy surgery can help people lose more weight after the surgery; better improve conditions like Type 2 diabetes, high blood pressure, high cholesterol, and sleep apnea after surgery and; whether this causes more complications or side effects compared to surgery alone.

Timeline

Start
2025-03-10
Primary completion
2027-09
Completion
2028-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Tirzepatide Peptide 5 mg

Indications